Regulus Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell RGLS and other ETFs, options, and stocks.About RGLS
Regulus Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of drugs targeting microRNAs. Its two lead product candidates, RG-012 and RGLS4326, are in clinical development.
CEOJoseph P. Hagan
CEOJoseph P. Hagan
Employees30
Employees30
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded2007
Founded2007
Employees30
Employees30
RGLS Key Statistics
Market cap145.99M
Market cap145.99M
Price-Earnings ratio-1.42
Price-Earnings ratio-1.42
Dividend yield—
Dividend yield—
Average volume263.26K
Average volume263.26K
High today$2.29
High today$2.29
Low today$2.22
Low today$2.22
Open price$2.29
Open price$2.29
Volume91.74K
Volume91.74K
52 Week high$3.79
52 Week high$3.79
52 Week low$1.08
52 Week low$1.08